Food, Global Health 2 min

Probing the protein used by SARS-CoV-2 to infect cells

PRESS RELEASE - To cause infection, viruses must enter the cells of their hosts. Viruses thus sport proteins on their membrane surfaces that allow their membranes to fuse with those of host cells. In collaboration with researchers at Cornell University in the US, INRAE researchers characterised a key surface protein found in SARS-CoV-2, the virus responsible for COVID-19. The group discovered that SARS-CoV-2 possesses a surface protein that is distinct from the surface proteins of other closely related coronaviruses. This difference in surface proteins might have played an important role in the evolution and emergence of SARS-CoV-2. These findings were recently published in the Journal of Molecular Biology.

Published on 28 April 2020

illustration Probing the protein used by SARS-CoV-2 to infect cells

Like all viruses, coronaviruses are essentially vessels carrying genetic information, which is packaged alongside viral proteins within a lipid membrane. In the case of SARS-CoV-2, this genetic information is in the form of RNA. Viruses are obligate intracellular parasites—they need the resources found inside of host cells to reproduce. To enter a cell, a virus must have a surface protein that can bind to a receptor (also a type of protein) on the membrane surface of a host cell. This type of interaction is highly specific—imagine a key fitting into a lock—and it allows the virus's membrane to fuse with the host cell's membrane. The virus can then release its genetic material inside the cell and begin to replicate. In this study, the researchers focused on a surface protein found in coronaviruses: the spike protein. The spike protein plays a major role in virus entry into target cells because it attaches to a host cell receptor and thus mediates the process of membrane fusion. The cell receptor targeted by SARS-CoV-2 is called ACE2 (i.e., angiotensin-converting enzyme 2). It is the same receptor used by SARS-CoV, the pathogen responsible for the 2002–2003 SARS epidemic. Using protein sequence alignment, phylogenetic analysis1, and structural modelling, the researchers compared and contrasted the spike protein of SARS-CoV-2 with those of other coronaviruses.

For membrane fusion to occur, the spike protein must be recognised and precisely cut by the host cell receptor, which is an enzyme. This process can only occur at specific locations along the spike protein, called cleavage sites. The researchers found that the cleavage site of SARS-CoV-2's spike protein has an extra peptide fragment, an insert that is four amino acids long. This insert is absent from the spike proteins of SARS-CoV and other closely related coronaviruses in mammals such as the bat and the pangolin.

Structural modelling revealed that SARS-CoV-2's cleavage site is a loop that could be recognised by proteases; this conformation results from the presence of the insert. SARS-CoV-2 is thus structurally distinct from other closely related coronaviruses, a trait that may have played a major role in the virus’s evolution and emergence.

The results of this study lay the foundation for functional research on the spike protein, which could clarify how SARS-CoV-2 infects cells and spreads within the human population.

1Phylogenetic analysis examines phylogenetic trees, which are diagrams that represent evolutionary relationships among biological entities.


Jaimes JA et al., Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop, Journal of Molecular Biology, DOI: 10.1016/j.jmb.2020.04.009




Jean Millet Molecular Virology and Immunology (VIM) Research Unit



Learn more

Food, Global Health

COVID-19: Tackling the Epidemic in 20 Research Projects

PRESS RELEASE - At a time when the Sars-CoV-2 epidemic is continuing to spread, France’s Alliance for Life Sciences and Health (Aviesan) is mobilizing to accelerate research into the virus and COVID-19 disease through REACTing – a consortium coordinated by Inserm. With the support of the Ministry of Solidarity and Health and the Ministry of Higher Education, Research and Innovation, the Scientific Advisory Board of REACTing has selected 20 scientific initiatives covering diverse fields, from mathematical modelling to disease prevention and treatment.

12 March 2020

COVID-19: INRAE supports clinical research and hospitals

On Friday 20 March, INRAE launched an inventory of the human and material resources which it could put at the disposal of healthcare institutions and personnel. This inventory is being carried out under the supervision of the Presidents of INRAE’s research centres throughout France. More than 71,000 masks including 26,000 FFP2 & FFP3 masks, more than 2,300 litres of hydroalcoholic solution or equivalent, as well as glasses, head covers, gloves, shoe covers, disposable gowns and overalls have been collected. This initiative strengthens and coordinates local initiatives already in place and helps them meet the requests and requirements of the university hospitals and regional health agencies. At the request of the Ministry of Higher Education, Research and Innovation, the initiative is conducted in coordination with our 4 partners: CNRS, INSERM, CEA, INRIA.

23 March 2020

Food, Global Health

Q&A with Muriel Vayssier-Taussat, CARE member: what comes after the lockdown

The Council for Analysis, Research, and Expertise (CARE), established by the French government on 24 March 2020, comprises a group of 12 researchers and medical doctors with different specialties. CARE is tasked with quickly providing guidance to the French government on matters related to coronavirus treatment and testing. Muriel Vayssier-Taussat, the head of INRAE’s scientific division for animal health and director of the Carnot Institute Livestock Industry for the Future, describes her first experience on the council.

02 April 2020